🇺🇸 FDA
Company

Stoke

Stoke Therapeutics

STOK pharma USA

Quick answer

Stoke is a pharma company (STOK) headquartered in BEDFORD, MA, USA with 6 tracked pipeline programs.

Pipeline (6)

project

zorevunersen

Dravet Syndrome

Phase 3 · small_molecule · active

1 trials project

Milrinone

Valvular Stenosis

Phase 2 · small_molecule · completed

1 trials project

STK-001 - Single Ascending Doses

Dravet Syndrome

Phase 2 · small_molecule · completed

1 trials project

zorevunersen (STK-001)

Dravet Syndrome

Phase 2 · small_molecule · active

1 trials project

Pethidine

Pain Relief in Labour

Approved · small_molecule · completed

1 trials project

Transanal irrigation with Peristeen Anal Irrigation

Constipation

Approved · other · completed

1 trials

Patents (8)

patent

US 12338437

OPA1 antisense oligomers for treatment of conditions and diseases

Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12060558

Methods and compositions for treatment of cholesteryl ester storage disease

Expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11873490

Antisense oligomers for treatment of conditions and diseases

Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11814622

OPA1 antisense oligomers for treatment of conditions and diseases

Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11096956

Antisense oligomers and uses thereof

Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11083745

Antisense oligomers for treatment of autosomal dominant mental retardation-5 and

Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10913947

Antisense oligomers for treatment of conditions and diseases

Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10683503

Antisense oligomers for treatment of conditions and diseases

Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)